Aug 09, 2021 06:08 PM (GMT+8) · EqualOcean
Fosun Pharmaceutical announced that the holding subsidiary Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. has received the approval of the State Drug Administration on approving its participation in the development of fh-2001 capsule for clinical trials of advanced malignant solid tumors. Fosun Pharmaceutical industry plans to carry out the phase I clinical trial of the new drug in China (excluding Hong Kong, Macao and Taiwan, the same below).